MK-677
most data
The Dose Guy’s verdictAug 28, 20265 sources
MK-677 reliably raises GH and IGF-1, and it is oral. That convenience is real and it is why people reach for it. The price is also real: appetite that hits like a wall, water retention that masks whatever body composition you were chasing, and a glucose and insulin hit that arrives fast and does not fully clear. On a bulk or for sleep, with monitoring, it has a place. On a cut it will fight you every meal.
What it is
MK-677 is not a peptide. It is a small oral molecule that acts on the ghrelin receptor, the same receptor ipamorelin hits, making it a growth-hormone secretagogue you can swallow instead of inject. The ghrelin receptor does not only release GH. It also drives hunger, which is why MK-677’s appetite spike is not a side effect but part of the mechanism. Your pituitary fires a GH pulse, your IGF-1 climbs over weeks, and your stomach tells you it is time to eat, all from the same switch.
That makes MK-677 a tool with a clear use case and a clear wrong use case. On a lean bulk, the elevated GH, the better deep sleep, and the appetite all pull in the same direction. On a cut, you are fighting the compound’s primary action every day. If you want GH-axis support without the hunger, the injectable secretagogues like ipamorelin or a GHRH analog like CJC-1295 are the cleaner path.
What the research shows
MK-677 has more human data than most compounds in this category, with randomized trials running up to two years. The story is consistent: GH and IGF-1 go up, lean mass ticks up, strength and function do not follow, and glucose takes a hit:
Realistic protocols
Start low and give the hunger time to settle. The trial dose is 25 mg daily, but 10 to 15 mg is where most people begin to assess tolerance. Take it before bed: you sleep through the worst of the appetite surge, and the GH pulse lines up with your natural overnight secretion. The hunger is intense for the first two to four weeks and usually fades to manageable, but it does not disappear. If you are cutting, this is the wrong compound.
Water retention shows up fast, sometimes pounds of it in the first week. It is not tissue growth, it is fluid, and it will mask scale changes. Judge progress by the mirror and measurements, not body weight. Monitor fasting glucose from the start and recheck every few weeks. If it starts climbing and does not settle, that is your signal to reassess.
Side effects
The ghrelin receptor does more than release GH, and MK-677’s side profile reflects it:
